Temporal characterization of marburg virus angola infection following aerosol challenge in rhesus macaques

Journal of Virology

Volumn 89, Issue 19, 2015, Pages 9875-9885

  Lin, Kenny L ^a   Twenhafel, Nancy A ^a   Connor, John H ^b   Cashman, Kathleen A ^a   Shamblin, Joshua D ^a   Donnelly, Ginger C ^a   Esham, Heather L ^a   Wlazlowski, Carly B ^a   Johnson, Joshua C ^a,c   Honko, Anna N ^a,c   Botto, Miriam A ^a   Yen, Judy ^b   Hensley, Lisa E ^a,c   Goff, Arthur J ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; AEROSOL; CYTOKINE;

ADULT; AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; HYPERTRANSAMINASEMIA; HYPOALBUMINEMIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LEUKOCYTOSIS; LIVER DESTRUCTION; LIVER DISEASE; LONGITUDINAL STUDY; LUNG ALVEOLUS MACROPHAGE; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS VARIANT ANGOLA; MARBURGVIRUS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; TH1 CELL; TH2 CELL; TIME SERIES ANALYSIS; UPREGULATION; UREA NITROGEN BLOOD LEVEL; UREMIA; VIREMIA; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BLOOD; HOST PATHOGEN INTERACTION; PATHOGENICITY; PATHOPHYSIOLOGY; TIME;

AEROSOLS; ANIMALS; CYTOKINES; DISEASE PROGRESSION; HOST-PATHOGEN INTERACTIONS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; MACACA MULATTA; MARBURG VIRUS DISEASE; MARBURGVIRUS; TIME FACTORS; VIRAL LOAD;

EID: 84940977042     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01147-15     Document Type: Article

References (33)

1. Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. 2011. Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror 9:361-371. http://dx.doi.org/10.1089/bsp.2011.0051.
2. Slenczka W, Klenk HD. 2007. Forty years of Marburg virus. J Infect Dis 196(Suppl 2):S131-S135. http://dx.doi.org/10.1086/520551.
3. Brauburger K, Hume AJ, Muhlberger E, Olejnik J. 2012. Forty-five years of Marburg virus research. Viruses 4:1878-1927. http://dx.doi.org/10.3390/v4101878.
4. LeDuc JW. 1989. Epidemiology of hemorrhagic fever viruses. Rev Infect Dis 11(Suppl 4):S730-S735. http://dx.doi.org/10.1093/clinids/11.Supplement_4.S730.
5. Shu HL, Siegert R, Slenczka W. 1969. The pathogenesis and epidemiology of the "Marburg-virus" infection. Ger Med Monthly 14:7-10.
6. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, Sleurs H, Campbell P, Tshioko FK, Roth C, Colebunders R, Pirard P, Mardel S, Olinda LA, Zeller H, Tshomba A, Kulidri A, Libande ML, Mulangu S, Formenty P, Grein T, Leirs H, Braack L, Ksiazek T, Zaki S, Bowen MD, Smit SB, Leman PA, Burt FJ, Kemp A, Swanepoel R, International S, Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of the Congo. 2006. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 355:909-919. http://dx.doi.org/10.1056/NEJMoa051465.
7. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Stroher U, Gomes da Silva F, del Castillo F, Rollin PE, Ksiazek TG, Nichol ST. 2006. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 80:6497-6516. http://dx.doi.org/10.1128/JVI.00069-06.
8. Kuhn JH. 2008. Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies. Arch Virol Suppl 20:13-360.
9. Ligon BL. 2005. Outbreak of Marburg hemorrhagic fever in Angola: a review of the history of the disease and its biological aspects. Sem Pediatr Infect Dis 16:219-224. http://dx.doi.org/10.1053/j.spid.2005.05.001.
10. Weingartl HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G. 2012. Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2:811. http://dx.doi.org/10.1038/srep00811.
11. Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. 2010. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 109:1531-1539. http://dx.doi.org/10.1111/j.1365-2672.2010.04778.x.
12. U.S. Food and Drug Administration. 2002. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Reg 67:37988-37998.
13. Alves DA, Glynn AR, Steele KE, Lackemeyer MG, Garza NL, Buck JG, Mech C, Reed DS. 2010. Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques. Vet Pathol 47:831-851. http://dx.doi.org/10.1177/0300985810378597.
14. Nakayama E, Saijo M. 2013. Animal models for Ebola and Marburg virus infections. Front Microbiol 4:267. http://dx.doi.org/10.3389/fmicb.2013.00267.
15. Bente D, Gren J, Strong JE, Feldmann H. 2009. Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2:12-17. http://dx.doi.org/10.1242/dmm.000471.
16. Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, Young HA, Formenty P, Fritz EA, Larsen T, Hensley LE. 2007. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 196(Suppl 2):S372-S381. http://dx.doi.org/10.1086/520608.
17. Hensley LE, Alves DA, Geisbert JB, Fritz EA, Reed C, Larsen T, Geisbert TW. 2011. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. J Infect Dis 204(Suppl 3):S1021-S1031. http://dx.doi.org/10.1093/infdis/jir339.
18. Murphy FA, Simpson DI, Whitfield SG, Zlotnik I, Carter GB. 1971. Marburg virus infection in monkeys. Ultrastructural studies. Lab Invest 24:279-291.
19. Simpson DI. 1969. Marburg agent disease: in monkeys. Trans R Soc Trop Med Hyg 63:303-309. http://dx.doi.org/10.1016/0035-9203(69)90002-9.
20. Connor JH, Yen J, Caballero IS, Garamszegi S, Malhotra S, Lin K, Hensley L, GoffA. 2015. Transcriptional profiling of the immune response to Marburg virus infection. J Virol 89:9865-9874. http://dx.doi.org/10.1128/JVI.01142-15.
21. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
22. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, Kulesh DA. 2010. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg 82:954-960. http://dx.doi.org/10.4269/ajtmh.2010.09-0636.
23. Hartman AL, Towner JS, Nichol ST. 2010. Ebola and marburg hemorrhagic fever. Clin Lab Med 30:161-177. http://dx.doi.org/10.1016/j.cll.2009.12.001.
24. Mehedi M, Groseth A, Feldmann H, Ebihara H. 2011. Clinical aspects of Marburg hemorrhagic fever. Future Virol 6:1091-1106. http://dx.doi.org/10.2217/fvl.11.79.
25. Kortepeter MG, Bausch DG, Bray M. 2011. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 204(Suppl 3):S810-S816. http://dx.doi.org/10.1093/infdis/jir299.
26. Mohamadzadeh M, Chen L, Schmaljohn AL. 2007. How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 7:556-567. http://dx.doi.org/10.1038/nri2098.
27. Bausch DG, Sprecher AG, Jeffs B, Boumandouki P. 2008. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antivir Res 78:150-161. http://dx.doi.org/10.1016/j.antiviral.2008.01.152.
28. Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, Stroher U, Hensley LE, Grolla A, Fritz EA, Feldmann F, Feldmann H, Jones SM. 2006. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol 80:9659-9666. http://dx.doi.org/10.1128/JVI.00959-06.
29. van Paassen J, Bauer MP, Arbous MS, Visser LG, Schmidt-Chanasit J, Schilling S, Olschlager S, Rieger T, Emmerich P, Schmetz C, van de Berkmortel F, van Hoek B, van Burgel ND, Osterhaus AD, Vossen AC, Gunther S, van Dissel JT. 2012. Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever. Lancet Infect Dis 12:635-642. http://dx.doi.org/10.1016/S1473-3099(12)70018-X.
30. van Den Broek M, Bachmann MF, Kohler G, Barner M, Escher R, Zinkernagel R, Kopf M. 2000. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol 164:371-378. http://dx.doi.org/10.4049/jimmunol.164.1.371.
31. Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA. 1996. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 70:7103-7107.
32. Carsillo M, Klapproth K, Niewiesk S. 2009. Cytokine imbalance after measles virus infection has no correlation with immune suppression. J Virol 83:7244-7251. http://dx.doi.org/10.1128/JVI.00148-09.
33. Lee S, Almeida CA, French MA, Price P. 2004. Persistent HIV-1 replication does not explain low levels of T-cell interferon gamma mRNA and elevated serum NO2-/NO3 - in patients with stable CD4 T-cell responses to HAART. Clin Exp Immunol 138:110-115. http://dx.doi.org/10.1111/j.1365-2249.2004.02589.x.